Received Mar 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMAB072A | — |
Menveo was administered to a patient that had been reconstituted with sterile water instead of the liquid conjugate portion; Menveo was administered to a patient that had been reconstituted with sterile water instead of the liquid conjugate portion; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAB072A, expiry date 30-APR-2026) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Menveo was administered to a patient that had been reconstituted with sterile water instead of the liquid conjugate portion) and inappropriate dose of vaccine administered (Verbatim: Menveo was administered to a patient that had been reconstituted with sterile water instead of the liquid conjugate portion). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable.